US FDA, USP Cooperate On Small Molecule Drug Monograph Updates To Speed ANDAs

 
• By Derrick Gingery
  
Generics
Using the USP Pending Monograph Process could help generics reach the market faster, US FDA says. • Source: Shutterstock

More from Generics

More from Biosimilars & Generics